Genome-wide CRISPR screening reveals mTOR inhibition triggers ferritinophagy and ferroptosis, suggesting potential cancer therapies.
Ferrostatin-1 attenuated the effects of mTORi and auranofin by suppressing ferroptosis in vivo. (Related to Figure 7)
No takes yet. Share an insight, caveat, or question.
Koshizuka et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: